Our competitors seem to think their therapy "is expected to become the first drug used for ARDS" ... Interesting
Novartis and MSB might have something to say about this .... I guess we will see soon enough ..... or maybe Novartis have jumped ship and gone over to Athersys ... LMAO
https://www.clinicaltrialsarena.com/news/healios-cell-therapy-ards/
Healios reports positive data of cell therapy in ARDS patients
09 Aug 2021 (Last Updated August 9th, 2021 11:52)
The stem cell regenerative therapy is expected to become the first drug used for ARDS, which has no direct treatment to date.
In addition, the mortality rate 90 days after the treatment in the HLCM051 arm was 39% lesser than in the standard therapy arm, observed to be 26.3% versus 42.9%, respectively.
“Three of these Covid-19-induced ARDS patients were able to have the ventilator removed within three days of intubation.”
Our competitors seem to think their therapy "is expected to...
-
- There are more pages in this discussion • 7,514 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |